Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Polymorphism in the Yersinia LcrV Antigen Enables Immune Escape From the Protection Conferred by an LcrV-Secreting Lactococcus Lactis in a Pseudotuberculosis Mouse Model.

Daniel C, Dewitte A, Poiret S, Marceau M, Simonet M, Marceau L, Descombes G, Boutillier D, Bennaceur N, Bontemps-Gallo S, Lemaître N, Sebbane F.

Front Immunol. 2019 Aug 2;10:1830. doi: 10.3389/fimmu.2019.01830. eCollection 2019.

2.

Validity as a social imperative for assessment in health professions education: a concept analysis.

Marceau M, Gallagher F, Young M, St-Onge C.

Med Educ. 2018 Jun;52(6):641-653. doi: 10.1111/medu.13574.

PMID:
29878449
3.

Horizontal acquisition of a hypoxia-responsive molybdenum cofactor biosynthesis pathway contributed to Mycobacterium tuberculosis pathoadaptation.

Levillain F, Poquet Y, Mallet L, Mazères S, Marceau M, Brosch R, Bange FC, Supply P, Magalon A, Neyrolles O.

PLoS Pathog. 2017 Nov 27;13(11):e1006752. doi: 10.1371/journal.ppat.1006752. eCollection 2017 Nov.

4.

Evaluation of the Role of the opgGH Operon in Yersinia pseudotuberculosis and Its Deletion during the Emergence of Yersinia pestis.

Quintard K, Dewitte A, Reboul A, Madec E, Bontemps-Gallo S, Dondeyne J, Marceau M, Simonet M, Lacroix JM, Sebbane F.

Infect Immun. 2015 Sep;83(9):3638-47. doi: 10.1128/IAI.00482-15. Epub 2015 Jul 6.

5.

Yersinia pestis requires the 2-component regulatory system OmpR-EnvZ to resist innate immunity during the early and late stages of plague.

Reboul A, Lemaître N, Titecat M, Merchez M, Deloison G, Ricard I, Pradel E, Marceau M, Sebbane F.

J Infect Dis. 2014 Nov 1;210(9):1367-75. doi: 10.1093/infdis/jiu274. Epub 2014 May 9.

PMID:
24813471
6.

Proposed reclassification of Pasteurella lymphangitidis Sneath & Stevens 1990 as Yersinia pseudotuberculosis.

Gaillot O, Lemenand O, Marceau M, Simonet M.

Int J Syst Evol Microbiol. 2013 Oct;63(Pt 10):3927-9. doi: 10.1099/ijs.0.051524-0. Epub 2013 Aug 6.

PMID:
23919959
7.

Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis.

Supply P, Marceau M, Mangenot S, Roche D, Rouanet C, Khanna V, Majlessi L, Criscuolo A, Tap J, Pawlik A, Fiette L, Orgeur M, Fabre M, Parmentier C, Frigui W, Simeone R, Boritsch EC, Debrie AS, Willery E, Walker D, Quail MA, Ma L, Bouchier C, Salvignol G, Sayes F, Cascioferro A, Seemann T, Barbe V, Locht C, Gutierrez MC, Leclerc C, Bentley SD, Stinear TP, Brisse S, Médigue C, Parkhill J, Cruveiller S, Brosch R.

Nat Genet. 2013 Feb;45(2):172-9. doi: 10.1038/ng.2517. Epub 2013 Jan 6.

8.

A case of bupropion-induced stuttering.

Fetterolf F, Marceau M.

Gen Hosp Psychiatry. 2013 Sep-Oct;35(5):574.e7-8. doi: 10.1016/j.genhosppsych.2012.07.003. Epub 2012 Sep 5.

PMID:
22959418
9.

In silico comparison of Yersinia pestis and Yersinia pseudotuberculosis transcriptomes reveals a higher expression level of crucial virulence determinants in the plague bacillus.

Chauvaux S, Dillies MA, Marceau M, Rosso ML, Rousseau S, Moszer I, Simonet M, Carniel E.

Int J Med Microbiol. 2011 Feb;301(2):105-16. doi: 10.1016/j.ijmm.2010.08.013. Epub 2010 Oct 15.

PMID:
20951640
10.

An iron-regulated LysR-type element mediates antimicrobial peptide resistance and virulence in Yersinia pseudotuberculosis.

Arafah S, Rosso ML, Rehaume L, Hancock RE, Simonet M, Marceau M.

Microbiology. 2009 Jul;155(Pt 7):2168-81. doi: 10.1099/mic.0.026690-0. Epub 2009 Apr 23.

PMID:
19389764
11.

Growth of Yersinia pseudotuberculosis in human plasma: impacts on virulence and metabolic gene expression.

Rosso ML, Chauvaux S, Dessein R, Laurans C, Frangeul L, Lacroix C, Schiavo A, Dillies MA, Foulon J, Coppée JY, Médigue C, Carniel E, Simonet M, Marceau M.

BMC Microbiol. 2008 Dec 3;8:211. doi: 10.1186/1471-2180-8-211.

12.

Therapeutic potential of Yersinia anti-inflammatory components.

Foligné B, Dessein R, Marceau M, Poiret S, Dewulf J, Pot B, Simonet M, Daniel C.

Adv Exp Med Biol. 2007;603:361-6. Review.

PMID:
17966432
13.
14.

Transcriptome analysis of Yersinia pestis in human plasma: an approach for discovering bacterial genes involved in septicaemic plague.

Chauvaux S, Rosso ML, Frangeul L, Lacroix C, Labarre L, Schiavo A, Marceau M, Dillies MA, Foulon J, Coppée JY, Médigue C, Simonet M, Carniel E.

Microbiology. 2007 Sep;153(Pt 9):3112-24.

PMID:
17768254
15.

Phenotypic analysis of Yersinia pseudotuberculosis 32777 response regulator mutants: new insights into two-component system regulon plasticity in bacteria.

Flamez C, Ricard I, Arafah S, Simonet M, Marceau M.

Int J Med Microbiol. 2008 Apr;298(3-4):193-207. Epub 2007 Aug 31.

PMID:
17765656
16.

Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.

Foligne B, Dessein R, Marceau M, Poiret S, Chamaillard M, Pot B, Simonet M, Daniel C.

Gastroenterology. 2007 Sep;133(3):862-74. Epub 2007 Jun 20.

PMID:
17678918
17.

Describing ancient horizontal gene transfers at the nucleotide and gene levels by comparative pathogenicity island genometrics.

Collyn F, Guy L, Marceau M, Simonet M, Roten CA.

Bioinformatics. 2006 May 1;22(9):1072-9. Epub 2005 Nov 22.

PMID:
16303795
18.

Transcriptional regulation in Yersinia: an update.

Marceau M.

Curr Issues Mol Biol. 2005 Jul;7(2):151-77. Review.

19.

The pmrF polymyxin-resistance operon of Yersinia pseudotuberculosis is upregulated by the PhoP-PhoQ two-component system but not by PmrA-PmrB, and is not required for virulence.

Marceau M, Sebbane F, Ewann F, Collyn F, Lindner B, Campos MA, Bengoechea JA, Simonet M.

Microbiology. 2004 Dec;150(Pt 12):3947-57.

PMID:
15583148
20.

Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis.

Chain PS, Carniel E, Larimer FW, Lamerdin J, Stoutland PO, Regala WM, Georgescu AM, Vergez LM, Land ML, Motin VL, Brubaker RR, Fowler J, Hinnebusch J, Marceau M, Medigue C, Simonet M, Chenal-Francisque V, Souza B, Dacheux D, Elliott JM, Derbise A, Hauser LJ, Garcia E.

Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13826-31. Epub 2004 Sep 9.

21.

The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence.

Grabenstein JP, Marceau M, Pujol C, Simonet M, Bliska JB.

Infect Immun. 2004 Sep;72(9):4973-84.

22.

YAPI, a new Yersinia pseudotuberculosis pathogenicity island.

Collyn F, Billault A, Mullet C, Simonet M, Marceau M.

Infect Immun. 2004 Aug;72(8):4784-90.

23.

Yersinia pseudotuberculosis anti-inflammatory components reduce trinitrobenzene sulfonic acid-induced colitis in the mouse.

Marceau M, Dubuquoy L, Caucheteux-Rousseaux C, Foligne B, Desreumaux P, Simonet M.

Infect Immun. 2004 Apr;72(4):2438-41.

24.

Attenuated virulence of Streptococcus agalactiae deficient in D-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells.

Poyart C, Pellegrini E, Marceau M, Baptista M, Jaubert F, Lamy MC, Trieu-Cuot P.

Mol Microbiol. 2003 Sep;49(6):1615-25.

25.

Function and regulation of the Salmonella-like pmrF antimicrobial peptide resistance operon in Yersinia pseudotuberculosis.

Marceau M, Sebbane F, Collyn F, Simonet M.

Adv Exp Med Biol. 2003;529:253-6. No abstract available.

PMID:
12756767
26.

Yersinia pseudotuberculosis harbors a type IV pilus gene cluster that contributes to pathogenicity.

Collyn F, Marceau M, Simonet M.

Adv Exp Med Biol. 2003;529:89-95. No abstract available.

PMID:
12756734
27.

Yersinia pseudotuberculosis harbors a type IV pilus gene cluster that contributes to pathogenicity.

Collyn F, Léty MA, Nair S, Escuyer V, Ben Younes A, Simonet M, Marceau M.

Infect Immun. 2002 Nov;70(11):6196-205.

28.

The superantigen gene ypm is located in an unstable chromosomal locus of Yersinia pseudotuberculosis.

Carnoy C, Floquet S, Marceau M, Sebbane F, Haentjens-Herwegh S, Devalckenaere A, Simonet M.

J Bacteriol. 2002 Aug;184(16):4489-99.

29.
30.
32.

Consequences of the loss of O-linked glycosylation of meningococcal type IV pilin on piliation and pilus-mediated adhesion.

Marceau M, Forest K, Béretti JL, Tainer J, Nassif X.

Mol Microbiol. 1998 Feb;27(4):705-15.

33.

Type-4 pili and meningococcal adhesiveness.

Nassif X, Marceau M, Pujol C, Pron B, Beretti JL, Taha MK.

Gene. 1997 Jun 11;192(1):149-53. Review.

PMID:
9224885
34.
35.

Effects of different training intensities on 24-hour blood pressure in hypertensive subjects.

Marceau M, Kouamé N, Lacourcière Y, Cléroux J.

Circulation. 1993 Dec;88(6):2803-11.

PMID:
8252694
36.

NMR spectra of exchangeable protons of pyridoxal phosphate-dependent enzymes.

Metzler CM, Metzler DE, Kintanar A, Scott RD, Marceau M.

Biochem Biophys Res Commun. 1991 Jul 15;178(1):385-92.

PMID:
2069576
38.
41.
42.

Increased HLA-DR antigen expression in human hepatocytes after liver transplantation: kinetic analysis using fine needle aspiration biopsy.

Zannier A, Faure JL, Mutin M, Marceau M, Brochier J, Revillard JP.

Transplant Proc. 1988 Apr;20(2):202-4. No abstract available.

PMID:
3284041
43.

[Primary biliary cirrhosis: therapeutic trial using plasma exchange and immunosuppression. Preliminary results].

Rifle G, Mousson C, Hillon P, Marceau M, Chalopin JM, Tanter Y.

Ann Med Interne (Paris). 1988;139 Suppl 1:32-4. French.

PMID:
3247987
44.
45.

Preparation of a biologically active rat prolactin devoid of antidiuretic activity.

Adler RA, Marceau M, Borst DW, Sokol HW, Culp WJ.

Endocrinology. 1982 Feb;110(2):674-6.

PMID:
7056218
46.

[Triangular cervical flap in the primary reconstruction of the buccopharyngeal cavity].

Poisson R, Daigle L, Gagnon A, Marceau M, Ostiguy M, Klemchuck S, Franchebois P.

Union Med Can. 1974 Aug;103(8):1420-8. French. No abstract available.

PMID:
4603940
47.

[Experimental study on tumorgenic effects of lubricants used in metal screw cutting].

Dargent M, Marceau M, Joseph P, Faucon M.

Rev Lyon Med. 1967 May 30;16(10):410-9. French. No abstract available.

PMID:
5609680

Supplemental Content

Loading ...
Support Center